Publicaciones RedinRen

• Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy.

  Rodríguez-Peña AB, Fuentes-Calvo I, Docherty NG, Arévalo M, Grande MT, Eleno N et al.. Biomed Res Int. 2014;2014:124902.

• Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats.

  Blázquez-Medela AM, García-Sánchez O, Blanco-Gozalo V, Quiros Y, Montero MJ, Martínez-Salgado C et al.. PLoS One. 2014;9(8):e105988.

• Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.

  Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodriguez JI, Sánchez-Rodríguez A, López-Novoa JM. Eur J Clin Invest. 2012 May;42(5):548-56.

• H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts.

  Fuentes-Calvo I, Blázquez-Medela AM, Eleno N, Santos E, López-Novoa JM, Martínez-Salgado C. Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C686-97.

• Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.

  López-Hernández FJ, López-Novoa JM. Cell Tissue Res. 2012 Jan;347(1):141-54.

• Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model.

  Kurdián M, Herrero-Fresneda I, Lloberas N, Gimenez-Bonafe P, Coria V, Grande MT. PLoS One. 2012;7(3):e32516.

• Angiogenic stimuli and endoglin absence induces brain arteriovenous malformations: are local endoglin deletion and angiogenesis the 'second hit' that is necessary for arteriovenous malformations formation in HHT-1?

  Lopez-Novoa JM. Cerebrovasc Dis. 2012;33(6):548.

• Functional specific roles of H-ras and N-ras. A proteomic approach using knockout cell lines.

  Ferreira L, Fuentes-Calvo I, Muñoz-Félix JM, Muñiz-Martín C, Sánchez-Juanes F, Raposo C. Electrophoresis. 2012 May;33(9-10):1385-96.

• Subcellular targets of cisplatin cytotoxicity: an integrated view.

  Sancho-Martínez SM, Prieto-García L, Prieto M, López-Novoa JM, López-Hernández FJ. Pharmacol Ther. 2012 Oct;136(1):35-55.

• Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration.

  Rossi E, Sanz-Rodriguez F, Eleno N, Düwell A, Blanco FJ, Langa C. Blood. 2013 Jan 10;121(2):403-15.

• Oxysterol-induced soluble endoglin release and its involvement in hypertension.

  Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nuñez M, Llano E. Circulation. 2012 Nov 27;126(22):2612-24.

• Effects and mechanism of organ protection by cardiotrophin-1.

  García-Cenador MB, Lopez-Novoa JM, Díez J, García-Criado FJ. Curr Med Chem. 2013;20(2):246-56.

• Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats.

  Vicente-Vicente L, Ferreira L, González-Buitrago JM, López-Hernández FJ, López-Novoa JM, Morales AI. Toxicology. 2013 Feb 8;304:83-91.

• Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats.

  Quiros Y, Sánchez-González PD, López-Hernández FJ, Morales AI, López-Novoa JM. Toxicol Sci. 2013 Apr;132(2):493-501.

• Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet.

  Beiroa D, Romero-Picó A, Langa C, Bernabeu C, López M, López-Novoa JM. PLoS One. 2013;8(1):e54591.

• Alteration in endoglin-related angiogenesis in refractory cytopenia with multilineage dysplasia.

  del Rey M, Pericacho M, Velasco S, Lumbreras E, López-Novoa JM, Hernández-Rivas JM. PLoS One. 2013;8(1):e53624.

• Endoglin haploinsufficiency promotes fibroblast accumulation during wound healing through Akt activation.

  Pericacho M, Velasco S, Prieto M, Llano E, López-Novoa JM, Rodríguez-Barbero A. PLoS One. 2013;8(1):e54687.

• The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

  González-Núñez M, Muñoz-Félix JM, López-Novoa JM. Biochim Biophys Acta. 2013 Oct;1832(10):1492-510.

• Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability.

  Pérez-Gómez E, Jerkic M, Prieto M, del Castillo G, Martín-Villar E, Letarte M. J Invest Dermatol. 2014 Jan;134(1):247-55.

• Membrane and soluble forms of endoglin in preeclampsia.

  Oujo B, Perez-Barriocanal F, Bernabeu C, Lopez-Novoa JM. Curr Mol Med. 2013 Sep;13(8):1345-57.

• The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts.

  Fuentes-Calvo I, Crespo P, Santos E, López-Novoa JM, Martínez-Salgado C. Biochim Biophys Acta. 2013 Dec;1833(12):2734-2744.

• Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.

  Muñoz-Félix JM, López-Novoa JM, Martínez-Salgado C. Kidney Int. 2014 Feb;85(2):319-32.

• Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome.

  Fernandes-Cerqueira C, Sampaio-Maia B, Quelhas-Santos J, Moreira-Rodrigues M, Simões-Silva L, Blazquez-Medela AM. Biomed Res Int. 2013;2013:397391.

• Met signaling in cardiomyocytes is required for normal cardiac function in adult mice.

  Arechederra M, Carmona R, González-Nuñez M, Gutiérrez-Uzquiza A, Bragado P, Cruz-González I. Biochim Biophys Acta. 2013 Dec;1832(12):2204-15.

• ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe?

  Muñoz-Félix JM, González-Núñez M, López-Novoa JM. Cytokine Growth Factor Rev. 2013 Dec;24(6):523-37.

• Cardiotrophin-1 administration protects from ischemia-reperfusion renal injury and inflammation.

  Garcia-Cenador MB, Lorenzo-Gomez MF, Herrero-Payo JJ, Ruiz J, Perez de Obanos MP, Pascual J. Transplantation. 2013 Dec 27;96(12):1034-42.

• Interferon-γ Reduces the Proliferation of Primed Human Renal Tubular Cells.

  García-Sánchez O, López-Novoa JM, López-Hernández FJ. Nephron Extra. 2014 Jan;4(1):1-7.

• ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts.

  Muñoz-Félix JM, Perretta-Tejedor N, Eleno N, López-Novoa JM, Martínez-Salgado C. Biochim Biophys Acta. 2014 Jun;1843(6):1111-22.